Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding.

Autor:	Furniss RCD; MRC Centre for Molecular Bacteriology and Infection, Department of Life Sciences, Imperial College London, London, United Kingdom., Kaderabkova N; MRC Centre for Molecular Bacteriology and Infection, Department of Life Sciences, Imperial College London, London, United Kingdom.; Department of Molecular Biosciences, University of Texas at Austin, Austin, United States., Barker D; MRC Centre for Molecular Bacteriology and Infection, Department of Life Sciences, Imperial College London, London, United Kingdom., Bernal P; Department of Microbiology, Faculty of Biology, Universidad de Sevilla, Seville, Spain., Maslova E; Division of Biosciences, Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United Kingdom., Antwi AAA; MRC Centre for Molecular Bacteriology and Infection, Department of Life Sciences, Imperial College London, London, United Kingdom., McNeil HE; Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Pugh HL; Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Dortet L; MRC Centre for Molecular Bacteriology and Infection, Department of Life Sciences, Imperial College London, London, United Kingdom.; Department of Bacteriology-Hygiene, Bicêtre Hospital, Assistance Publique - Hôpitaux de Paris, Le Kremlin-Bicêtre, France.; EA7361 'Structure, Dynamics, Function and Expression of Broad-spectrum β-lactamases', Paris-Sud University, LabEx Lermit, Faculty of Medicine, Le Kremlin-Bicêtre, France.; French National Reference Centre for Antibiotic Resistance, Le Kremlin-Bicêtre, France., Blair JMA; Institute of Microbiology and Infection, College of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom., Larrouy-Maumus G; MRC Centre for Molecular Bacteriology and Infection, Department of Life Sciences, Imperial College London, London, United Kingdom., McCarthy RR; Division of Biosciences, Department of Life Sciences, College of Health and Life Sciences, Brunel University London, Uxbridge, United Kingdom., Gonzalez D; Laboratoire de Microbiologie, Institut de Biologie, Université de Neuchâtel, Neuchâtel, Switzerland., Mavridou DAI; MRC Centre for Molecular Bacteriology and Infection, Department of Life Sciences, Imperial College London, London, United Kingdom.; Department of Molecular Biosciences, University of Texas at Austin, Austin, United States.; John Ring LaMontagne Center for Infectious Diseases, University of Texas at Austin, Austin, United States.
Jazyk:	angličtina
Zdroj:	ELife [Elife] 2022 Jan 13; Vol. 11. Date of Electronic Publication: 2022 Jan 13.
DOI:	10.7554/eLife.57974
Abstrakt:	Antimicrobial resistance in Gram-negative bacteria is one of the greatest threats to global health. New antibacterial strategies are urgently needed, and the development of antibiotic adjuvants that either neutralize resistance proteins or compromise the integrity of the cell envelope is of ever-growing interest. Most available adjuvants are only effective against specific resistance proteins. Here, we demonstrate that disruption of cell envelope protein homeostasis simultaneously compromises several classes of resistance determinants. In particular, we find that impairing DsbA-mediated disulfide bond formation incapacitates diverse β-lactamases and destabilizes mobile colistin resistance enzymes. Furthermore, we show that chemical inhibition of DsbA sensitizes multidrug-resistant clinical isolates to existing antibiotics and that the absence of DsbA, in combination with antibiotic treatment, substantially increases the survival of Galleria mellonella larvae infected with multidrug-resistant Pseudomonas aeruginosa . This work lays the foundation for the development of novel antibiotic adjuvants that function as broad-acting resistance breakers. Competing Interests: RF, NK, DB, PB, EM, AA, HM, HP, LD, JB, GL, RM, DG, DM No competing interests declared (© 2022, Furniss et al.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu